Two studies have found that the virus that causes COVID-19 is becoming resistant to two drugs used to treat patients with ...

Children with prenatal pandemic exposure and/or exposure to maternal severe acute respiratory syndrome coronavirus 2 ...

Wildlife species linked to SARS-CoV-2 in Wuhan's Huanan Seafood Market, shedding light on the origins of the COVID-19 ...

This new article publication from Acta Pharmaceutica Sinica B, discusses how SARS-CoV-2 ORF10 hijacking ubiquitination machinery reveals potential unique drug targeting sites.

The following is a summary of “Early, robust mucosal secretory IgA but not IgG response to SARS-CoV-2 spike in oral fluid is ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of news releases posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Varanasi: In a major breakthrough in the global fight against the SARS-CoV-2 virus, a team of researchers from the Centre for Genetic Disorders at Ban.

Molnupiravir, an antiviral drug used to treat patients with COVID-19, appears to be driving SARS-CoV-2 to mutate and evolve, with some of these new viruses being transmitted onwards, a new study has ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of news releases posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

RESEARCH COULD PAVE THE WAY FOR FUTURE COVID-19 TREATMENTS GROUNDBREAKING INNOVATION WITH REGARD TO AYURVEDA IN FIGHT AGAINST COVID-19Varanasi : In a significant breakthrough against the SARS-CoV-2 ...

Here, the authors isolate a SARS-CoV-2 mutant that has developed decreased sensitivity to Paxlovid and remdesivir from an immunocompromised patient, show that drug resistance can be overcome by ...

The argument about the origins of COVID has always been heated, and nowadays it feels more like a brawl than a scientific ...